BSE - Delayed Quote INR

Novartis India Limited (NOVARTIND.BO)

Compare
1,040.20 -43.70 (-4.03%)
At close: 3:56 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Ms. Shilpa Shashank Joshi CFO & Whole-Time Director -- -- 1969
Ms. Chandni Maru Company Secretary & Compliance Officer -- -- --
Mr. Falin Majmudar Whole?Time Director -- -- 1968
Dr. Vasant Narasimhan M.D. Chief Executive Officer of Novartis -- -- 1976

Novartis India Limited

Inspire BKC
7th Floor Bandra-Kurla Complex Bandra (East)
Mumbai, 400051
India
91 22 50243000 https://www.novartis.in
Sector:?
Healthcare
Full Time Employees:?
62

Description

Novartis India Limited operates as a healthcare company in India. The company offers therapeutic products in the areas of bone and pain products under the Voveran brand; transplantation immunology products under the Simulect, Certican, Sandimmun, Neoral, and Myfortic brands. It also offers neurosciences products under the Tegrital and Exelon brands. Novartis India Limited was incorporated in 1947 and is based in Mumbai, India. The company is a subsidiary of Novartis AG.

Corporate Governance

Novartis India Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

October 25, 2024 at 10:59 AM UTC

Novartis India Limited Earnings Date

Recent Events

July 23, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers